-
MMJ Enters Agreement to Produce Cannabis-based Capsules for Clinical Trials in MS and Huntington’s
The GMP agreement may allow MMJ to open clinical studies of its THC-cannabidiol gel capsule as a potential treatment of spasticity in MS patients. Learn more here.
What do you think about this research news?
Sorry, there were no replies found.
Log in to reply.